EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing Viability in Static and Perfused 3D Tissue Constructs Using Sacrificial Gelatin Microparticles

Andrew R Hudson, Daniel J Shiwarski iD, Alec J Kramer iD, Adam W Feinberg iD

ACS Biomaterials Science & Engineering · 12.05.2025 · 11 (5) · 2888-2897

DOI: 10.1021/acsbiomaterials.4c02169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 07.04.2025. Verfasst von Andrew R Hudson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States. Hauptthemen laut MEDLINE: Gelatin, Tissue Scaffolds, Tissue Engineering. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Additional Ventures, U.S. Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current limitations in engineered tissues arise from the inability to provide sufficient nutrients to cells deep within constructs, restricting their viability. This study focuses on enhancing diffusion by creating a microporous microenvironment using gelatin microparticles within collagen scaffolds. By leveraging the FRESH (Freeform Reversible Embedding of Suspended Hydrogels) 3D bioprinting technique, gelatin microparticles are utilized both as a support material and as a thermoresponsive porogen to establish interconnected pores. The results indicate that scaffolds with 75% porosity significantly increase diffusion rates and cell viability, extending beyond the conventional ∼200 μm limit. Additionally, integrating vascular-like channels with porous scaffolds and applying perfusion improved nutrient transport, leading to enhanced cell survival in larger constructs. This combination of microporosity and perfusion represents a promising approach to create thicker tissues without necrotic regions, potentially paving the way for scalable tissue engineering applications. The findings suggest that optimizing pore sizes and scaffold perfusion can bridge the gap between rapid tissue formation and slower vascularization processes, enabling the future development of functional tissue constructs at clinically relevant scales.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GelatinTissue ScaffoldsTissue EngineeringCell SurvivalPorosityHumansHydrogelsPerfusionPrinting, Three-DimensionalAnimalsBioprinting

Stichwörter der Autor:innen

bioprintingperfusionporogenscaffoldtissue engineeringviability

Substanzen

GelatinHydrogels

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States.
  • Department of Materials Science & Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States.

ORCID-Profile: Daniel J Shiwarski, Alec J Kramer, Adam W Feinberg

Förderung

  • NHLBI NIH HHS
  • Additional Ventures
  • U.S. Department of Health and Human Services

Zitieren

APA

Hudson, A. R., Shiwarski, D. J., Kramer, A. J., & Feinberg, A. W. (2025). Enhancing Viability in Static and Perfused 3D Tissue Constructs Using Sacrificial Gelatin Microparticles. ACS Biomaterials Science & Engineering, 11(5), 2888-2897. https://doi.org/10.1021/acsbiomaterials.4c02169

Vancouver

Hudson AR, Shiwarski DJ, Kramer AJ, Feinberg AW. Enhancing Viability in Static and Perfused 3D Tissue Constructs Using Sacrificial Gelatin Microparticles. ACS Biomaterials Science & Engineering. 2025;11(5):2888-2897. doi:10.1021/acsbiomaterials.4c02169

BibTeX
@article{Hudson2025,
  author = {Hudson, Andrew R and Shiwarski, Daniel J and Kramer, Alec J and Feinberg, Adam W},
  title = {Enhancing Viability in Static and Perfused 3D Tissue Constructs Using Sacrificial Gelatin Microparticles},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2025},
  volume = {11},
  number = {5},
  pages = {2888--2897},
  doi = {10.1021/acsbiomaterials.4c02169}
}
Kostenlos starten →